The health benefits of fish oil, and its omega-3 long chain polyunsaturated fatty acid content,
have attracted much scientific attention in the last four decades. Fish oils that contain higher …

A large body of evidence supports the cardioprotective effects of the long-chain omega-3
polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), and docosahexaenoic …

Very-long chain omega-3 fatty acids (EPA and DHA) have anti-inflammatory properties that
may help reduce morbidity and mortality from COVID-19 infection. We conducted a pilot …

N-3 polyunsaturated fatty acids (PUFA) and the numerous families of lipid mediators derived
from them collectively regulate numerous biological processes. The mechanisms by which n …

Background It has long been believed that DHA supplementation increases plasma EPA via
the retroconversion pathway in mammals. However, in rodents this increase in EPA is likely …

Introduction The majority of the population do not consume adequate omega-3 fatty acids (n-
3 FA), leading to global deficiencies, as evidenced by poor omega-3 status. An indicator of …

Background Supplemental long-chain omega-3 (n–3) fatty acids (EPA and DHA) raise
erythrocyte EPA+ DHA [omega-3 index (O3I)] concentrations, but the magnitude or variability …

The results of several meta-analyses suggest that eicosapentaenoic acid (EPA)
supplementation is therapeutic in managing the symptoms of major depression. It was …

Atherosclerosis is a chronic inflammatory vascular disease that is characterized by the
accumulation of lipids and immune cells in plaques built up inside artery walls …

The aim of this trial is to assess the effect of Almega® PL on improving the Omega-3 Index,
cardio-metabolic parameters, and other biomarkers in generally healthy individuals. The …